Published in Proc Natl Acad Sci U S A on March 15, 1993
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev (2011) 2.54
Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol (1995) 1.88
Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J (1995) 1.88
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med (1997) 1.79
The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol (2008) 1.79
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med (2013) 1.75
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest (1997) 1.62
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol (1999) 1.48
PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J Clin Invest (2013) 1.42
Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation. Immunol Rev (2014) 1.38
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest (1995) 1.35
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci U S A (1997) 1.24
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses. Proc Natl Acad Sci U S A (2012) 1.16
A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology (1996) 1.16
Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol (1998) 1.15
Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain. Proc Natl Acad Sci U S A (1997) 1.09
bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol (1995) 1.06
Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J (1995) 1.04
Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res (2009) 1.02
Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance. Cancer Res (2009) 1.01
Murine retrovirus-induced depletion of T cells is mediated through activation-induced death by apoptosis. J Virol (1994) 0.98
Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol (1998) 0.95
Apoptosis and Bcl-2 expression in cultured murine splenic T cells. Immunology (1995) 0.87
Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival. Proc Natl Acad Sci U S A (1995) 0.85
Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease. Mediators Inflamm (1999) 0.82
The Effect of Q-Switched Nd:YAG 1064 nm/532 nm Laser in the Treatment of Onychomycosis In Vivo. Dermatol Res Pract (2013) 0.81
Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit. Immunology (1997) 0.81
Differential regulation of nuclear and mitochondrial Bcl-2 in T cell apoptosis. Apoptosis (2008) 0.79
Bcl-2 maintains the mitochondrial membrane potential, but fails to affect production of reactive oxygen species and endoplasmic reticulum stress, in sodium palmitate-induced β-cell death. Ups J Med Sci (2014) 0.75
Dying to protect: cell death and the control of T-cell homeostasis. Immunol Rev (2017) 0.75
Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells. Immunology (1994) 0.75
RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry (1977) 38.82
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (1990) 14.46
Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem (1988) 12.72
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell (1991) 8.13
Mechanisms and functions of cell death. Annu Rev Cell Biol (1991) 7.76
Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol (1984) 6.82
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol (1988) 6.51
Cell death during development of the nervous system. Annu Rev Neurosci (1991) 6.37
Genetic control of programmed cell death in the nematode C. elegans. Cell (1986) 6.04
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A (1991) 5.50
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Apoptosis and programmed cell death in immunity. Annu Rev Immunol (1992) 4.47
Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature (1992) 3.96
Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J (1989) 3.26
IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res (1986) 3.11
The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol (1990) 3.11
In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J Exp Med (1977) 3.11
Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell (1987) 2.12
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98
Activation-driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J Immunol (1989) 1.85
The toxic peptides from Amanita mushrooms. Int J Pept Protein Res (1983) 0.97
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci U S A (1985) 3.31
Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J Exp Med (1984) 2.86
Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J Exp Med (1983) 2.78
Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature (1983) 2.62
Structure and function of human perforin. Nature (1988) 2.47
Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins. J Exp Med (1979) 2.39
Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell (1986) 2.38
Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9. Nature (1982) 2.35
The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science (1986) 2.21
Purification of the sixth and seventh component of human complement without loss of hemolytic activity. J Immunol (1976) 2.02
Nucleotide sequence of cDNA and derived amino acid sequence of human complement component C9. Proc Natl Acad Sci U S A (1984) 2.01
Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement. Proc Natl Acad Sci U S A (1982) 1.96
Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. J Exp Med (1982) 1.92
The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol (1978) 1.81
Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins. Proc Natl Acad Sci U S A (1979) 1.76
Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components. J Immunol (1978) 1.76
The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med (1996) 1.72
Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J Biol Chem (1982) 1.70
C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J Immunol (1979) 1.63
C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions. J Exp Med (1979) 1.55
Cytolysis by Ca-permeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis. J Exp Med (1989) 1.54
Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci U S A (1989) 1.50
Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry (1985) 1.48
Functional channel formation associated with cytotoxic T-cell granules. Proc Natl Acad Sci U S A (1986) 1.43
Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci U S A (1979) 1.41
Structural similarities between C6 and C7 of human complement. J Immunol (1979) 1.41
Membrane attack by complement. Mol Immunol (1984) 1.39
The role of C9 in complement-mediated killing of Neisseria. J Immunol (1981) 1.35
The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol (1977) 1.35
Characterization of three serine esterases isolated from human IL-2 activated killer cells. J Immunol (1988) 1.33
Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J Immunol (1997) 1.33
Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Acta Pathol Microbiol Immunol Scand Suppl (1984) 1.32
Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8. Proc Natl Acad Sci U S A (1982) 1.30
Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol (1997) 1.29
Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J Immunol (1999) 1.29
The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. J Immunol (1981) 1.29
Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules. J Exp Med (1986) 1.27
Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut (2002) 1.25
SC5b-9 complex of complement: formation of the dimeric membrane attack complex by removal of S-protein. J Immunol (1980) 1.25
The C5b-6 complex: reaction with C7, C8, C9. J Immunol (1978) 1.25
Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med (1982) 1.25
Structure of the human perforin gene. A simple gene organization with interesting potential regulatory sequences. J Immunol (1989) 1.24
Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol (1989) 1.24
Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol (1996) 1.20
Structure and expression of murine CD30 and its role in cytokine production. J Immunol (1996) 1.20
Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun (1993) 1.19
Membrane attack complex of complement: a structural analysis of its assembly. J Exp Med (1980) 1.19
Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc Natl Acad Sci U S A (1997) 1.19
The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase. J Immunol (1980) 1.18
The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. J Immunol (1985) 1.15
Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes. J Cell Biochem (1986) 1.12
CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol (1999) 1.09
The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex. J Immunol (1976) 1.09
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Oncogene (2001) 1.08
Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol (1998) 1.07
Membrane attack complex of complement. Evidence for its dimeric structure based on hybrid formation. J Biol Chem (1981) 1.06
Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum Gene Ther (1995) 1.03
Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells. J Immunol (1992) 1.03
Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes. J Immunol (1989) 1.02
Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J Immunol (1998) 1.01
Membranolysis by the ninth component of human complement. Biochem Biophys Res Commun (1981) 1.00
Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood (1998) 0.98
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas. Br J Cancer (2009) 0.98
Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J Immunol (1993) 0.98
Membrane attack complex of complement: distribution of subunits between the hydrocarbon phase of target membranes and water. Proc Natl Acad Sci U S A (1981) 0.97
Cellular localization of perforin 1 in murine cloned cytotoxic T lymphocytes. J Immunol (1987) 0.96
Membrane attach complex of complement (MAC): three-dimensional analysis of MAC-phospholipid vesicle recombinants. J Immunol (1982) 0.96
Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol (1992) 0.96
Resistance and susceptibility of neural cells to lysis by cytotoxic lymphocytes and by cytolytic granules. Transplantation (1992) 0.95
Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin. Arthritis Rheum (1997) 0.94
CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol (2000) 0.94
Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells. Cancer Res (1988) 0.93
Molecular weight of poly(C9). 12 to 18 C9 molecules form the transmembrane channel of complement. J Biol Chem (1984) 0.93
Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem (1979) 0.93
Molecular composition of the tubular structure of the membrane attack complex of complement. J Biol Chem (1984) 0.92
Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice. Br J Cancer (1993) 0.92
Limited proteolysis of C5b-6: functional stability of the degraded complex. J Immunol (1980) 0.92
The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7. J Immunol (1985) 0.92
Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol (1994) 0.91
Transgenic control of perforin gene expression. Functional evidence for two separate control regions. J Immunol (1995) 0.91
Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. J Biol Chem (1986) 0.90
CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology (2001) 0.90
Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa. Mucosal Immunol (2009) 0.89
In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant. J Cancer Res Clin Oncol (1994) 0.88
Perforin-2 restricts growth of Chlamydia trachomatis in macrophages. Infect Immun (2013) 0.88
On the mechanism of malonyl-CoA independent fatty acid synthesis. II. Isolation, properties and subcellular location of trans-2,3-hexenoyl-CoA and trans-2,3-decenoyl-CoA reductase. Biochim Biophys Acta (1972) 0.87
Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int Immunol (1996) 0.86
Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol (1999) 0.86
Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. J Immunol (1994) 0.85
Mechanisms and physiological roles of fatty acid chain elongation in microsomes and mitochondria. Mol Cell Biochem (1973) 0.85
Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J Immunol (1996) 0.85
Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-kappa B. Oncogene (1997) 0.85
Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant? Immunol Today (2000) 0.85
Granule-mediated cytolysis of target cells. Curr Top Microbiol Immunol (1989) 0.84
Perforin and granzyme B as markers for acute rejection in heart transplantation. Int Immunol (1991) 0.84
Review: neuronal injury in HIV infection. J Neurovirol (1999) 0.84
Analysis of perforin expression in human peripheral blood lymphocytes, CD56+ natural killer cell subsets and its induction by interleukin-2. Immunol Invest (1995) 0.84
Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis. J Immunol (1979) 0.84
Perforin expression in endometrium during the menstrual cycle. Int J Gynecol Pathol (1995) 0.84